Filing Details
aTYR PHARMA INC (NASDAQ:ATYR) filed a Form 8-K with the Securities and Exchange Commission on October 27, 2026, disclosing a material event.
8k filedNASDAQ:ATYR
aTYR PHARMA INC (ATYR) Reports Material Event to SEC
aTYR PHARMA INC (NASDAQ:ATYR) filed a Form 8-K with the Securities and Exchange Commission on October 27, 2026, disclosing a material event.
At publication ·
What changed
aTYR PHARMA INC (NASDAQ:ATYR) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- aTYR PHARMA INC filed a Form 8-K with the SEC on October 27, 2026, disclosing a material event that shareholders should know about.
- The company's stock trades at $0.12 per share with a market capitalization of $74.8 million.
- Material events in 8-K filings can include leadership changes, agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
aTYR PHARMA INC's stock currently trades at $0.12 with a market capitalization of $74.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for aTYR PHARMA INC's stock.
All SEC filings for aTYR PHARMA INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ATYR Stock Page
Frequently Asked Questions
Where can I read ATYR's SEC filings?
Browse all filings on our ATYR SEC filings page.
What types of SEC filings does aTYR PHARMA INC file?
Public companies like aTYR PHARMA INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
